← Open Payments lookup

SUZANNE LIND: Open Payments

NPI 1437250644 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,165 in 156 payments from 11 companies in 2025. Trend: 2023 $1,091 · 2024 $2,167 · 2025 $12,165

Speaker / faculty: $9,030Food & beverage: $3,135
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.35$9,701
Alkermes, Inc.17$601
Neurocrine BioSciences, Inc.23$546
ABBVIE INC.22$371
E.R. Squibb & Sons, L.L.C.21$330
Janssen Pharmaceuticals, Inc15$201
Luye Pharma (USA) Ltd.8$136
Otsuka America Pharmaceutical, Inc.6$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$96
Almatica Pharma LLC2$33

Products named: UZEDY, INGREZZA, ARISTADA, VRAYLAR, COBENFY, LYBALVI, INVEGA SUSTENNA, AUSTEDO XR.

Industry payments across NJ — which companies pay providers there.